Kato Masafumi, Yoneyama-Hirozane Mariko, Iwasaki Katsuhiko, Matsubayashi Mao, Igarashi Ataru
Japan Pharma Business Unit, Takeda Pharmaceutical Company Limited, Tokyo, Japan.
Department of Data Science, Medilead, Inc, Tokyo, Japan.
J Mark Access Health Policy. 2023 Jan 15;11(1):2166374. doi: 10.1080/20016689.2023.2166374. eCollection 2023.
Perianal fistula (PF), a complication of Crohn's disease (CD), affects health-related quality of life (QOL).
To elucidate QOL of health states corresponding to different stages of PF associated with CD in Japan.
This cross-sectional, observational, web-based questionnaire survey assessed eight different health states in patients with CD and PF and individuals without CD (non-patients) from the Medilead Healthcare Panel (MHP) and determined the utility values (QOL scores) in each health state by the time trade-off method. In patients, we determined also the utility value of the current health state associated with CD and the PF. The analysis excluded respondents with logical inconsistencies.
The analysis included 82 patients and 576 non-patients with the same sex and age distribution as the Japanese population. In both groups, mean utility values were higher in remission (patients, 0.78; non-patients, 0.51) than in non-remission states, with lowest values for poor prognosis after proctectomy (patients, 0.13; non-patients, -0.10) and highest values for the state with mild symptoms (patients, 0.60; non-patients, 0.30). In patients, the mean utility value of the current health state was 0.71.
QOL decreases with increasing severity of PF and is lower for good prognosis after proctostomy than for remission.
肛周瘘管(PF)是克罗恩病(CD)的一种并发症,会影响健康相关生活质量(QOL)。
阐明日本与CD相关的PF不同阶段对应的健康状态的生活质量。
这项横断面、观察性、基于网络的问卷调查评估了来自Medilead医疗保健小组(MHP)的CD和PF患者以及无CD个体(非患者)的八种不同健康状态,并通过时间权衡法确定了每种健康状态下的效用值(生活质量得分)。在患者中,我们还确定了与CD和PF相关的当前健康状态的效用值。分析排除了存在逻辑不一致的受访者。
分析纳入了82例患者和576例非患者,其性别和年龄分布与日本人群相同。在两组中,缓解期的平均效用值(患者为0.78;非患者为0.51)均高于非缓解期,直肠切除术后预后不良状态的效用值最低(患者为0.13;非患者为 -0.10),症状较轻状态的效用值最高(患者为0.60;非患者为0.30)。在患者中,当前健康状态的平均效用值为0.71。
生活质量随着PF严重程度的增加而降低,直肠造口术后预后良好状态的生活质量低于缓解期。